sertraline has been researched along with ADDH in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avci, A; Erken, E; Gul Celik, G; Ray, PC; Tas, DA; Yolga Tahiroglu, A | 1 |
| Ginsburg, G; Halldorsdottir, T; Kendall, PC; Ollendick, TH; Piacentini, J; Sakolsky, DJ; Sherrill, J; Walkup, J | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Christensen, C; Debes, NM; Kruuse, C; Leth, G; Martinussen, M; Pagsberg, AK | 1 |
| Vitiello, B | 1 |
| Geffken, GR; Goldstein, RB; Goodman, WK; Lehmkuhl, H; Murphy, TK; Storch, EA | 1 |
| Birkett, DP | 1 |
| Gupta, N; Mendhekar, DN | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Abbasi, SH; Akhondzadeh, S; Ashrafi, M; Hosseini, F; Modabbernia, A | 1 |
| Reiner, WG; Scharko, AM | 1 |
| Cummins, TK; Kratochvil, CJ; Martin, A; Varley, C | 1 |
| Coffey, B; Kotcher, L; Wieland, N | 1 |
| Chiu, S; Hagerman, R; Hendren, R; Hessl, D; Solomon, M | 1 |
| Barton, R | 1 |
| Koran, LM; Thienemann, M | 1 |
| Frankenburg, FR; Kando, JC | 1 |
| Findling, RL | 1 |
| Feeney, DJ; Klykylo, WM | 1 |
| Rand, EH | 1 |
| Beech, MJ | 1 |
| Ghaziuddin, N; Iqbal, A; Khetarpal, S | 1 |
1 review(s) available for sertraline and ADDH
| Article | Year |
|---|---|
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
3 trial(s) available for sertraline and ADDH
| Article | Year |
|---|---|
Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Cognitive Behavioral Therapy; Comorbidity; Female; Follow-Up Studies; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2015 |
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Topics: Adult; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Biomarkers; Celecoxib; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Interleukin-6; Male; Middle Aged; Outcome Assessment, Health Care; Pyrazoles; Sertraline; Sulfonamides | 2012 |
Do soft signs predict treatment outcome in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adult; Attention Deficit Disorder with Hyperactivity; Double-Blind Method; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Middle Aged; Neuropsychological Tests; Obsessive-Compulsive Disorder; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
18 other study(ies) available for sertraline and ADDH
| Article | Year |
|---|---|
Periodic fever and hyperimmunoglobulin D syndrome in a boy with pediatric autoimmune neuropsychiatric disorders associated with group A β-Hemolytic streptococcus.
Topics: Attention Deficit Disorder with Hyperactivity; Autoimmune Diseases; Child; Humans; Male; Mevalonate Kinase Deficiency; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Streptococcal Infections; Streptococcus pyogenes; Stuttering; Tourette Syndrome | 2013 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
[Development of cerebral infarcts in a 17-year-old male treated with sertraline and lisdexamfetamine].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Infarction; Depressive Disorder; Diffusion Magnetic Resonance Imaging; Humans; Lisdexamfetamine Dimesylate; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder.
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Propylamines; Risperidone; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2009 |
Behavioral therapy, sertraline, or both in childhood anxiety.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognitive Behavioral Therapy; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Use of sertraline in childhood retentive encopresis.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Constipation; Encopresis; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Ssri-induced sexual dysfunction in adolescents.
Topics: Adolescent; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Cross-Sectional Studies; Depressive Disorder; Female; Hospitals, University; Humans; Male; Psychiatric Department, Hospital; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 2004 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depression; Dibenzothiazepines; Domestic Violence; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Irritable Mood; Length of Stay; Male; Methylphenidate; Patient Admission; Psychiatric Department, Hospital; Psychomotor Agitation; Psychotropic Drugs; Quetiapine Fumarate; Recurrence; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Valproic Acid | 2006 |
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Fluoxetine; Humans; Male; Mental Status Schedule; Obsessive-Compulsive Disorder; Referral and Consultation; Sertraline; Tourette Syndrome; Trichotillomania | 2007 |
A genetic etiology of pervasive developmental disorder guides treatment.
Topics: Adolescent; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Development Disorders, Pervasive; Comorbidity; Female; Fragile X Syndrome; Humans; Occupational Therapy; Phenotype; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndrome.
Topics: 1-Naphthylamine; Adult; Aggression; Attention; Attention Deficit Disorder with Hyperactivity; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tourette Syndrome | 1994 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Medication-induced seizures.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Depression; Drug Therapy, Combination; Humans; Male; Methylphenidate; Seizures; Sertraline | 1997 |
Priapism in a patient taking sertraline.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Humans; Male; Middle Aged; Priapism; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Sertraline-induced hypomania presenting as hyperactivity disorder.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Child; Diagnosis, Differential; Female; Humans; Prognosis; Sertraline | 2000 |
Myoclonus during prolonged treatment with sertraline in an adolescent patient.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Clonazepam; Female; Humans; Methylphenidate; Myoclonus; Pseudotumor Cerebri; Risk Factors; Sertraline | 2001 |